HM Centro Integral Oncologico Clara Campal

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Melanoma2 trials
• Triple-negative breast cancer2 trials
• Bladder cancer1 trial
• Cervical cancer1 trial
• Diffuse large B-cell lymphoma1 trial
• Gastric and oesophageal cancer1 trial
• Head and neck cancer1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial
• Ovarian cancer1 trial

Phase

• Phase 11 trial
• Phase 1/21 trial
• Phase 21 trial

Status

• Completed2 trials
• Terminated1 trial

Lead sponsor

• Seagen Inc.2 trials
• Iovance Biotherapeutics, Inc.1 trial

Closed trials

• Terminated

  A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer

  NCT04254107· Phase 1· Seagen Inc.· Source

• Completed

  Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer

  NCT03310957· Phase 1/2· Seagen Inc.· Source

• Completed

  Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma

  NCT02360579· Phase 2· Iovance Biotherapeutics, Inc.· Source